Arkansans have spent $193.126 million on medical marijuana at the state’s 37 approved dispensaries in the first seven months of 2025, up 5.8% compared with sales in the same period of 2025, according to the Arkansas Department of Finance and Administration (DFA).
The DFA noted in the sales report posted Wednesday (Sept. 10) that sales are on pace to set a new record.
“A total of $1.5 billion has been spent on medical marijuana since the state’s first dispensary opened in May 2019,” said DFA spokesman Scott Hardin. “With daily sales averaging about $800,000 in 2025, we are on track to surpass the 2023 sales record of $283 million.”
More than $5.38 million in tax revenue was collected in July and August from medical marijuana, which brings total tax revenue to $21.57 million through August, up from $20.5 million in the same period of 2024, according to DFA information.
The Arkansas Department of Health reported 109,060 active patient cards as of the August report, down from the 110,539 in June, but up 12% compared with the 97,374 to begin 2024.
Following are the top five dispensaries, among the state’s 37 licensed dispensaries, for pounds sold in August.
• Suite 443 (Hot Springs): 714.31 pounds
• Natural Relief (Sherwood): 654.98
• CROP (Jonesboro): 406.63
• Custom Cannabis (Alexander): 389.41
• Harvest (Conway): 384.74
Suite 443 in Hot Springs led the state with 5,515 pounds sold in the first eight months of 2025, according to DFA. Suite 443 was the first dispensary to open in the state.
Following are the annual sales since 2019 when medical marijuana sales began in Arkansas.
2024: $275.9 million
2023: $283 million
2022: $276.3 million
2021: $264.9 million
2020: $181.8 million
2019: $31.32 million
The constitutional amendment legalizing medical marijuana for 17 qualifying conditions and creating a state medical marijuana commission was approved by Arkansas voters 53% to 47% in November 2016.
Taxes collected are 6.5% of regular state sales tax with each purchase by a patient and a 4% privilege tax on sales from cultivators to dispensaries. Most of the tax revenue is placed in the University of Arkansas for Medical Sciences National Cancer Designation Trust Fund. The state also collects a cultivator privilege tax, which means tax revenue is not always tied to how much product is bought by consumers at dispensaries and the price for the product sold to dispensary customers.